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Abstract 
Objectives: Nonunions after bone fractures are usually treated surgically with risk of infections 
and failure of osteosynthesis. A noninvasive alternative is extracorporeal shock wave treatment 
(ESWT), which potentially stimulates bone regeneration. Therefore this review investigates 
whether ESWT is an effective and safe treatment for delayed-unions and nonunions.   
Data sources:  Embase.com, Medline ovid, Cochrane, Web-of-science, Pubmed publisher and 
Google scholar were systematically searched.   
Study selection: Inclusion criteria included studies with patients with delayed-union or 
nonunion treated with ESWT; inclusion of ≥10 patients; follow-up period ≥6 weeks. 
Data extraction: Assessment for risk of bias was done by two authors using the Cochrane tool. 
Union rates and adverse events were extracted from the studies.  
Data synthesis:  Two RCT’s and 28 non-randomized studies were included. One RCT was 
assessed at medium risk of bias, and reported similar union rates between ESWT-treated 
patients (71%) and surgery-treated patients (74%). The remaining 29 studies were at high risk 
of bias due to poor description of randomization (n=1), non-randomized allocation to control 
groups (n=2) or absence of control groups (n=26). The average union rate after ESWT in 
delayed-unions was 86%,  in nonunions 73%, and in nonunions after surgery 81%. Only minor 
adverse events were reported after ESWT. 
Conclusions: ESWT seems to be effective for the treatment of delayed-unions and nonunions. 
However, the quality of most studies is poor. Therefore, we strongly encourage conducting 
well-designed RCT’s to prove the effectiveness of ESWT, and potentially improve the treatment 
of nonunions as ESWT might be as effective as surgery but safer.  
Level of Evidence: Therapeutic Level II 
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Introduction 
Delayed-unions and nonunions are failures of bony healing after fractures, osteotomies or 
arthrodesis. In practice a wide variety exists in the exact definition of delayed-unions and 
nonunions depending on fracture site and criteria used for the assessment of bony union.1 In 
this review, we define delayed-unions as fractures that do not show radiological union three 
months after a fracture, and nonunions as fractures that do not show radiological union six 
months after a fracture.  
Literature shows that 3-5% of all fractures evolve into a nonunion, with highest nonunions rates 
reported in fractures of the scaphoid (16%), tibia (14%) and femur (14%).2, 3  Patients with 
nonunions suffer from pain and decreased function, which affects a patient’s daily routines and 
decreases their quality of life.4, 5  
Currently most nonunions are treated with surgery, which is considered to be the “golden 
standard”.6 Surgical treatment options of nonunions are overall quite successful, with union 
rates reported between 74% to 95%.7-10 However, complications can occur such as infection 
(5%), neurovascular damage (7%) or implant related problems requiring an additional surgery 
(5%). 7, 11, 12 Alternatively to surgery patients could be treated noninvasively, which could 
reduce the risk of these complications.  
 
A noninvasive treatment for delayed-unions and nonunions is extracorporeal shock wave 
therapy (ESWT). ESWT is a well-known treatment for fragmentation of kidney stones, but over 
the last decades ESWT has been increasingly used for bone growth stimulation. In 1991 
Valchanou and Michailov used ESWT for the treatment of delayed-unions and nonunions and 
reported bony union in 70 of 82 fractures without any complications.13 Subsequently to these 
promising results, more studies have been published in which ESWT was used for delayed-
union and nonunion treatment.  
 
Bone healing after ESWT might be stimulated due to an increase in neovascularization and an 
upregulation of angiogenic and osteogenic growth factors.14 Animal studies reported an 
increase of several growth factors after ESWT, which are important in bone regeneration (VEGF, 
TGF-beta 1 and BMP’s).15, 16 Also, it has been show that ESWT leads to an increased 
differentiation of bone marrow stem cells towards osteoprogenitor cells,17 and thickening of 
the cambium layer of the periosteum by proliferation of osteoprogenitor cells.18 Although the 
exact working mechanisms of ESWT is still unclear it has been hypothesized that the biological 
responses after ESWT are triggered by mechanotransduction, a process in which cells transform 
mechanical stimuli into biochemical signals.19 During ESWT pressure waves are generated by a 
piezoelectric, electromagnetic or electrohydraulic mechanism. The created pressure waves are 
characterized by a fast pressure rise, exposing tissue cells to shear and tensile forces. These 
forces might cause liberation of messengers from the extracellular matrix, which can activate 
genes in the cell nucleus, which induces an upregulation of growth factors.6, 19   
 
In 2010, Zelle et al.20 published a systematic review concerning the treatment of delayed-unions 
and nonunions with ESWT. They reported that treatment of delayed-unions and nonunions 
with ESWT was successful in approximately 75% of the fractures. However, this conclusion was 
based on ten cohort studies, which provided a poor level of evidence, and a risk of bias 
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assessment was not performed. Presently, the clinical application of ESWT for delayed-unions 
and nonunions has not widely spread, although more studies have been published since the 
review of Zelle et al..20 Therefore, the aim of this systematic review is to provide a 
comprehensive overview of the currently available literature concerning the effectiveness and 
safeness of ESWT in the clinical treatment of delayed-unions and nonunions.    
 
Method 
The protocol of this systematic review was prospectively registered in the International 
prospective register of systematic reviews (http://www.crd.york.ac.uk/prospero/; registration 
number CRD42016046120).  
 
Eligibility Criteria 
For this review we included studies that treated delayed-unions or nonunion with ESWT. See 
table 1 for a full-overview of all eligibility criteria.  
 
Literature search 
Six databases were systematically searched on the 10th of August 2017. The databases that 
were searched were Embase.com, Medline ovid, Cochrane, Web-of-science, Pubmed publisher 
and Google scholar. The search strategy that was used for the search of Medline Ovid is 
presented in table 2, and was adapted for the search of the other databases.  Also, reference 
lists of eligible articles were checked for eligible articles that were missed by our search 
strategy.  
 
Study selection 
Articles that were found by multiple databases were deduplicated. The articles were then 
included or excluded based on the eligibility criteria. Articles were first screened based on title 
and abstract. Eligible articles were again judged based on full-text. Both selection rounds were 
independently performed by two reviewers (AW and OJ). After each selection round the 
reviewers compared their selected articles, and disagreements were discussed and resolved by 
consensus.  A third reviewer (DM) was asked in case of an unsolved disagreement.  
 
Risk of bias assessment 
Risk of bias assessment was independently performed by two reviewers (AW and DM), using 
the Cochrane Risk of Bias tool for RCT’s.21 This tool contains six items, which can be scored as 
low, high or unclear risk of bias. The six items concern random sequence generation, allocation 
concealment, blinding of participants and personnel, blinding of outcome assessment, handling 
of incomplete outcome data, and selective outcome reporting. Discrepancies between the 
reviewers were discussed and resolved by consensus. Afterwards, studies were classified as 
being at low, moderate or high risk of bias. Studies were at low risk of bias if all 6 items were 
scored as low risk of bias. Moderate risk of bias was defined as ≥4 items scored as low risk of 
bias. Studies were at high risk of bias if <4 items were scored as low risk of bias.  
 
Data extraction 
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A data extraction sheet was established by the reviewers (AW, OJ, DM) for accurate data 
extraction. Data that were extracted are general characteristics of the participants including 
fracture sites according to the OTA classification22, general characteristics of the ESWT, union 
rates and adverse events.  Data were extracted from the studies by one reviewer (AW), who 
also completed a full check of the extracted data after the data extraction was completed.  
 
Primary outcome 
Our primary outcome is the union rate six months after ESWT. In studies that only reported 
absolute numbers of bony union, union rates were calculated.  If the union rate after six 
months was not reported, union rate was reported as has been done in the study (e.g. union 
rate and average healing time). 
The results of the studies will be presented based on the outcome of the risk of bias assessment 
(low risk of bias, moderate risk of bias and high risk of bias).  
 
Secondary outcome 
Our secondary outcome is the safety of ESWT. The number of adverse events and the kind of 
adverse events were extracted from the studies. Adverse events were graded based on the 
adapted Clavien-Dindo classification.23, 24 The Clavien-Dindo classification is a tool established in 
general surgery to grade the severity of complications after surgery. In this tool, adverse events 
are graded from 1-5, in which grade 1 indicates any deviation from normal postoperative 
course without the need for any additional interventions, and grade 5 is the most serious, 
indicating the death of a patient. 
 
Results 
Literature search 
The search resulted in 2780 studies, but after deduplication 1868 studies remained for 
screening. The screening based on title and abstract resulted in 73 potentially eligibly studies. 
After reading the full texts of those studies, 30 studies were found to be eligible. Screening of 
the reference lists of those articles did not result in any additional studies and therefore 30 
studies were included in this review (figure 1).  
 
Risk of bias assessment 
All 30 studies were assessed for risk of bias. After initial assessment, 173 of the 180 items were 
given the same score by both reviewers, and discrepancies were resolved by consensus. The 
results of the risk of bias assessment per study are shown in table 3. None of the studies was 
classified as being at low risk of bias. One study was classified as being at moderate risk of bias.8 
Twenty-nine studies were classified as being at high risk of bias.9, 10, 13, 25-50  
 
General characteristics of included studies 
Studies at moderate risk of bias 
In the RCT of Cacchio et al.8, 126 patients with nonunions of the long bones were randomly 
assigned to ESWT group 1, ESWT group 2 or to the surgical treatment group. Patients in ESWT 
group 1 were treated with an energy flux density of 0.40 mJ/mm2, patients in ESWT group 2 
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with an energy flux density of 0.70 mJ/mm2. The general characteristics of this RCT are shown 
in table 4a.  
 
Studies at high risk of bias  
From the 29 studies with a high risk of bias, one study was a RCT. In this RCT, 63 patients with 
nonunions of the long bones were randomly assigned to ESWT combined with transplantation 
of human autologous bone mesenchymal stems cells (hBMSCs) or only ESWT (table 4a).48  
Two studies at high risk of bias were retrospective non-randomized trials.9, 10 Both studies 
compared patients with nonunions that were treated with ESWT, with a surgery-treated control 
group. The general characteristics of the patients and ESWT-treatment are shown in table 4a. 
 
The remaining 26 studies were cohort studies without a control group, see table 4b for the 
general characteristics of the patients and of the ESWT-treatment. Nineteen of those studies 
treated nonunions in which the fracture was older than six months.25-31, 35, 36, 38, 39, 41-44, 46, 47, 49, 50 
Five of them also reported data on the treatment of delayed-unions, 29, 38, 43, 44, 49 however 
Everding et al. 49 was excluded from the results as they treated <10 delayed-unions. Seven 
studies did not report how they defined delayed-unions or nonunions.13, 32-34, 37, 40, 45  
Of the 26 studies, ten studies collected data prospectively,25, 26, 28, 30, 31, 36, 38, 39, 44, 47 five studies 
retrospectively, 34, 35, 41, 42, 49 and ten studies did not report if data were collected prospectively 
or retrospectively. 13, 27, 29, 32, 33, 40, 43, 45, 46, 50  
The general design of the cohort studies was that patients with delayed-unions or nonunions 
were treated with ESWT and were followed over time to see whether bony union did occur. 
 
Primary outcome: bony union 
Studies at moderate risk of bias 
The union rates reported by Cacchio et al.8 after six months were 70% for ESWT group 1, 71% 
for ESWT group 2 and 74% for the surgical group. Union rates were not significantly different 
between the groups (X2=0.08; p=0.95).  
 
Studies at high risk of bias  
The RCT of Zhai et al. 48 reported callus formation after six months in 55% of the patients who 
only received ESWT, and in 63% of the patients in the hBMSCs + ESWT group.   
In the non-randomized trials, Notarnicola et al.10 reported union rates at six months of 79%  in 
the ESWT group and 78% in the surgical group. Union rates between the two groups were not 
significantly different (X2=0.01; p=0.89). Furia et al.9 reported union rates of 91% in the ESWT 
group and 90% in the surgical group after six months. No statistical analysis was done in this 
study.  
The union rates that were reported in the 26 cohort studies, are shown in figure 2, and vary 
between 39%-100%.  
The overall union rates of all studies at high risk of bias are presented in table 5.  
 
Secondary outcome: adverse events  
Cacchio et al.8, Notarnicola et al.10 and  Furia et al. 9 compared adverse events between ESWT-
treated patients and surgery-treated patients. The absolute number of complications are 
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shown in table 6 and the overall complication rates in figure 3. The RCT of Zhai et al.48 did not 
register adverse events.  
 
Of the 26 included cohort studies, 23 studies registered adverse events after ESWT, 13, 25-37, 39, 41-
47, 49 treating a total of 2027 delayed-unions and nonunions. Eight studies reported that no 
adverse events occurred after ESWT.13, 32, 34, 36, 41, 42, 45, 47 Fifteen studies reported adverse events 
such as petechiae, local edema and hematoma’s,25-31, 33, 35, 37, 39, 43, 44, 46, 49 which are all grade 1 
complications.   
 
Discussion 
In this systematic review the effectiveness of ESWT in delayed-unions and nonunions was 
examined. The study of Cacchio et al.8 showed that ESWT is as effective as surgical treatment 
for patients with long-bone nonunions, with unions rates  between 71% and 74% after six 
months.8 Next to this study, two more studies were published, in which ESWT treatment was 
compared to a surgery treated control group. In concordance with the findings of Cacchio et 
al.,8 both studies did find similar union rates between ESWT-treated patients and surgery-
treated patients.9, 10 The results of these studies seem to indicate that ESWT is as effective as 
surgery in the treatment of nonunions. The RCT of Zhai et al. 48 showed that hBMSCs 
transplantation with ESWT is more effective than ESWT alone, which shows that ESWT might be 
more effective with a combined treatment.  These promising results are further supported by 
the included cohort studies, which together treated more than 2000 delayed-unions and 
nonunions and reported similar union rates as after surgery.   
However, although we were able to identify 30 studies concerning this topic, the overall quality 
of those studies was poor, due to high risks of bias within the studies. The RCT of Cacchio et al. 8 
was at moderate risk of bias and the results should therefore be interpreted with caution. The 
remaining 29 studies were all assessed as high risk of bias, due to missing control groups or 
non-randomized allocation to control groups, no blinding of the outcome assessors and 
participants, and unclear handling of incomplete data. Therefore, it is unadvisable to draw 
strong conclusions from these study results. 
 
In addition to effectiveness, we also aimed to investigate the safety of ESWT treatment for 
nonunions. Twenty-three of the 30 studies addressed adverse events, treating together more 
than 1500 delayed-unions and nonunions. None of those studies reported any serious adverse 
events after ESWT, whereas severe adverse events were reported after surgery. None of the 
adverse events reported after ESWT needed further treatment. Based on these results it seems 
that ESWT is a safer treatment option for delayed-unions and nonunions than surgery.   
 
Zelle et al.20 published a systematic review on the effectiveness of ESWT in 2010 based on 10 
studies. They suggested that approximately 75% of delayed-unions or nonunions could be 
treated successfully with ESWT, but that evidence is rather low because all ten studies were 
cohort studies20. Since the review of Zelle et al.,20 multiple studies have been published on the 
effectiveness of ESWT.9, 27, 35, 37-42 However, even after the conduction of those studies, the level 
of evidence remains low.  
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This review encountered some challenges and limitations. Firstly, as RCT’s are the golden 
standard to prove the effectiveness of a treatment, we decided to perform the risk of bias 
assessment with a tool for RCT’s. However, our search resulted in only two RCT’s, and therefore 
all non-randomized and cohort studies were judged as high risk of bias.  However, we believe 
that by using this tool,  the lack of well performed RCT’s is clearly pointed out. It is argued that 
nonunions are a biological end-point in which no further bone healing will occur and that 
therefore a control group is not necessary to prove the effectiveness of ESWT. However, no 
clear consensus does exist when this biological endpoint is reached. Marsh et al.51 showed that 
in patients with nonunions at six months, 50% experienced spontaneous fracture healing within 
the next four months. Biederman et al.43 compared these results with the results of several 
studies that applied ESWT, and concluded that ESWT does not seem to accelerate bone union 
compared to natural fracture healing in nonunions. Thus, the cohort studies without control 
group might wrongly attribute the natural fracture healing process to ESWT, even after six 
months of nonunion.43   
Secondly, there was a lot of heterogeneity within and between the studies. Most studies 
included in this review, included patients with fractures of different bones and with different 
types of delayed-unions and nonunions. Furthermore, studies used different energy settings for 
ESWT, differed in the number of shock waves applied to a fracture and the number of ESWT 
sessions that were done. Also, the type of anaesthesia differed between the studies (ranging 
from no anesthesia at all to general anesthesia) which might influence the effectiveness of 
ESWT52. Overall, due to the heterogeneity between the studies and the poor quality of the 
studies, combining the results in a meta-analysis would not have empowered our conclusion. 
More research should be done with homogeneous groups and shock wave parameters to be 
able to make recommendations about optimal shock wave parameters for particular fractured 
bones.  
Lastly, some of the included studies were published by the same research groups.25, 26, 30, 33, 34, 50 
Looking at the results of those studies, it seems that some participants might have been 
included in the analysis of more than one publication. Therefore, this review might 
overestimate the actual amount of subjects that have been treated with ESWT.  
 
In conclusion, the union rates that have been presented in this review after ESWT were 
comparable to union rates after surgery, and no serious adverse events have been reported 
after ESWT. Therefore, it seems that ESWT is as effective as surgery for the treatment of 
delayed-unions and nonunions, with less severe complications. However, the quality of the 
studies was poor and therefore the evidence for the effectiveness of ESWT for treatment of 
delayed-unions and nonunions is weak. We therefore hope that in the near future high quality 
RCT’s will be conducted on the effect of ESWT in nonunions. These studies are essential to 
potentially implement ESWT into standard care.  
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Figure 1. Flow chart of study selection 
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Figure 2. Union rates on the left x-axis and average healing times in months on the right x-axis reported in the 26 cohort studies. 
Error bars indicate the ranges in time to union after ESWT; # = study determined union rates at a fixed point of 6 months after ESWT; 
X = study did not report average union time; ^ = study did not report range in union time.   
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Figure 3. Overall complication rates based on the reported complications in the studies of 
Cacchio et al.8, Notarnicola et al.10, and Furia et al.9, classified by the adapted Clavien-Dindo 
classification23.   
 
 Table 1. Eligibility criteria 
Inclusion criteria Exclusion criteria 
- Patients with a delayed-union or nonunion 
who are treated with ESWT 
- Skeletally mature patients 
- An outcome measure quantifying bony union 
(x-ray, CT-scan) should be reported 
- Full text available in English, Spanish, German 
or Dutch 
- Peer reviewed study 
- (Randomized) controlled trials, prospective 
and retrospective cohort-studies 
- Follow-up period < 6 weeks 
- Less than 10 patients 
 
 
 
Table 2. Search strategy for Medline 
("High-Energy Shock Waves"/ OR (((shock OR pressure*) AND wave*) OR shockwave* OR eswt OR orthotrip*)) 
 AND 
(exp "Bone and Bones"/ OR exp "Bone Development"/ OR exp "Bone Remodeling"/ OR exp "Fractures, Bone"/ 
OR "Fracture Healing"/ OR "Bone Density"/ OR exp "Bone Diseases"/ OR (bone OR bones OR fracture* OR 
nonunion OR ((non OR delay*) ADJ3 (union* )) OR osteo* OR osseous OR intraosseous OR (avascular* ADJ3 
necro*) OR skelet* OR pseudarthrit* OR pseudoarthrit* OR (pseud* ADJ arthrit*)).ab,ti.) NOT (exp animals/ 
NOT humans/) 
 
Table 3. Results of risk of bias assessment of the individual studies with scores per item.   
 Items of the Cochrane Risk of Bias tool 
for RCT’s 
Overall risk of bias 
 1 2 3 4 5 6 
Cacchio8 2009 + + - + + ? Moderate risk of bias 
Zhai49 2016 ? ? - ? + ? High risk of bias 
Notarnicola10 2010 - - - - ? ? High risk of bias 
Furia9 2010 - - - - + ? High risk of bias 
Schaden45 2004 - - - - ? ? High risk of bias 
Stojadinovic39 2011 - - - - ? ? High risk of bias 
Schaden29 2001 - - - - ? ? High risk of bias 
Everding50 2016 - - - - + ? High risk of bias 
Biederman44 2003 - - - - - ? High risk of bias 
Vulpiani40 2012 - - - - ? ? High risk of bias 
Vogel25 1997a - - - - ? ? High risk of bias 
Alkhawashki42 2015 - - - - ? ? High risk of bias 
Rodríguez de Oya27 2011 - - - - ? ? High risk of bias 
Wang30  2001 - - - - - ? High risk of bias 
Xu47 2009 - - - - - ? High risk of bias 
Beutler37 1999  - - - - ? ? High risk of bias 
Vogel26  1997b - - - - ? ? High risk of bias 
Schoellner312002 - - - - ? ? High risk of bias 
Rompe28 2001 - - - - ? ? High risk of bias 
Elster362010 - - - - - ? High risk of bias 
Haffner48 2016 - - - - - ? High risk of bias 
Wang512009 - - - - ? ? High risk of bias 
Kuo43 2015 - - - - ? ? High risk of bias 
Moretti34 2009a - - - - ? ? High risk of bias 
Valchanou13 1991 - - - - ? ? High risk of bias 
Bara32 2007  - - - - - ? High risk of bias 
Czarnowska-Cubala31 2013 - - - - ? ? High risk of bias 
Moretti34 2009b - - - - ? ? High risk of bias 
Alvarez38 2011 - - - - - ? High risk of bias 
West46 2008 - - - - ? ? High risk of bias 
1= Random sequence generation; 2 = Allocation concealment; 3= Blinding of participants and personnel; 4= 
Blinding of outcome assessment; 5= Incomplete outcome data; 6= Selective reporting; + = low risk of bias; - = 
high risk of bias; ? = unclear risk of bias  
 
 
Table 4a. Characteristics of included controlled trials 
 Number 
of 
fractures 
Age in years 
(range) 
Males in 
percen-
tages 
Fracture sites 
 
Average 
months of 
non-union 
before ESWT 
(range) 
Percentage 
previously 
infected 
nonunions 
Type of nonunion in 
percentages 
Type of 
anesthe-
sia 
Treatment 
Hyper-
thropic 
Atro-
phic 
Oligo-
tropic 
Randomized controlled trial 
Cacchio8 2009 
Intervention
1 42 42.8  (NR) 76 
Long bones of 
the upper and 
lower 
extremities 
11.5 (NR) 
NR 
71 29 0 R ESWT (4x 4000 shocks at 0,40 mJ/mm²) 
Intervention 
2 42 43.1 (NR)) 74 10.8 (NR) 74 26 0 R 
ESWT (4x 4000 shocks at 
0,70 mJ/mm²) 
Control 42 42.5 (NR) 71 10.2 (NR) 74 26 0 G 
Surgical revision with 
fixation (locked 
intramedullary nail ± 
autogenous bone graft or 
external fixator) 
Zhai48 2016 
Intervention 32 39,6 (23 - 50) 56  Shaft of the 
long bones 
13,4 (9 -20) 
NR 
91 90 NR NR 
Transplantation of 
autologous hBMSC + 4-5x 
ESWT (mean of 2900 shock 
waves at average 23 kV) 
Control 31 38,1 (20 – 49) 58 12,9  (9 –19) 90 10 NR NR 
4-5x ESWT (mean of 2900 
shock waves at average 23 
kV) 
Non-randomized controlled trials 
Notarnico- 
la 10 2010 
Intervention 58 33,2 (16-65) 91 
Scaphoid 
14,8 (9-36) 
NR NR 
NR ESWT (3x 4000 shocks at 0,05-0,12 mJ/mm²) 
Control 60 33,1 (16-65) 87 15,8 (9-40) NR Surgery according to the Matti-Russe method 
Furia9  2010 
Intervention 23 42,7 (17-78) 57 Proximal metaphyseal-
diaphyseal part 
of the fifth 
metatarsal 
10,4 (6-39) 
NR NR 
G (n=15), 
R (n=6),  
L (n=2) 
ESWT (2000-4000 shocks at 
0.35 mJ/mm²) 
Control 20 40,8 (19-78) 40 6,2 (4-13) NR Intramedullary screw fixation 
 
 
 
Table 4b. General characteristics of the included cohort studies 
 Number 
of 
fractures 
Age in years 
(range) 
Males 
in 
percen-
tage 
Fracture sites Average 
months of 
non-union 
before ESWT 
(range) 
Percentage 
previously 
infected 
nonunions 
Type of nonunion in 
percentages 
Type of 
anesthe-
sia 
Number of 
shocks 
applied  
Energy 
density in 
mJ/mm² Hyper-
thropic 
Atro-
phic 
Oligo-
troph
ic 
Studies with delayed-unions (<6 months since fracture) and nonunions (≥ 6 months since fracture) 
Schaden44 2004 DU: 152 NU: 445 44 (10-90) 68 Upper + lower extremities  16,1 (NR) 10 39 61 G, R or L 2000-4000 0,38 
Stojadinovic38 2011 DU: 120  NU: 229  48 (15-91) 67 Upper + lower extremities NR NR NR NR NR G or R NR NR 
Schaden29 2001 DU: 35 NU: 80 43 (10-86)) 64 Upper + lower extremities  NR 19 NR NR NR 
G (n=60) 
R (n=51) 
L (n=4) 
1000-
12.000 0,25-0,40 
Everding49 2016 DU:9
a 
NU: 33 
43 (18-74) 72 Upper + lower extremities DU: 4,3 (3,5-5) NU:17,3 (6-48) NR 52 48 NR NR 3000 0,36 
Biederman43 2003 DU: 16 NU: 57 42 (NR) 53 Long bones: 58; others 12 
DU: 5 (0,2-5) 
NU: 19 (6-74)  
NR DU: 86 NU: 61 
DU: 14 
NU: 39 NR 
G (n=46), 
L (n=39) 
1-2x 2900 
(mean) 23 kV 
Studies with nonunions (≥ 6 months since fracture) 
Vulpiani39  2012 143 41 (14-81) 64 Upper + lower extremities 14,1 (6-84) NR 10 17 73 
L (n=17) 
NA 
(n=126)  
3-5x 2500-
3000 0,25-0,84 
Vogel25  1997a 52 37 (12-81) 62 Upper + lower extremities 13 (6-51) 15 NR NR NR R (n=51) NR (n=1) 3000 0,6 
Alkhawashki41 2015 49 34 (14-70) 80 Upper + lower extremities  11,9 (6-60) Excluded NR NR NR NR 1-3x 2000-4000 26 kV 
Rodríguez de Oya27  
2001 20 42 (26-62) 63 Upper + lower extremities 17 (6-42) NR 25 30 45 G or R 
3500 – 
10.000 0,3-0,4 
Wang30 2001 72 39 (15-74) 73 Long bones of the upper + lower extremities NR (NR) NR 53 18 29 G or R 1000-6000 0,47-0,62 
Xu46 2009 69 38 (22-72) 64 Long bones of the upper + lower extremities 12,5 (6-84) NR 84 16 NR R or L 
3000-
10.000 0,56-0,62 
Beutler36 1999 27 35 (19-72) NR Long bones of the upper + lower extremities 9 (6-16) NR 59 41 NR 
NA(n=24) 
NR (n=1)  2x 2000 18 kV 
Vogel26 1997b 48 38 (12-81) 52 Lower extremities 12 (6-48) 17 NR NR NR R (n=47) 3000 0,6 
NR  (n=1) 
Schoellner31 2002 43 39 (18-74) 53 Long bones of the lower extremities 13 (9-51) NR NR NR NR R 3000 0,6 
Rompe28 2001 43 40 (18-74) 53 Long bones of the lower extremities 11 (9-36) NR NR NR NR R 3000 0,6 
Elster35 2010 192 45 (16-90) 73 Tibia 16,8 (NR) 21 38 41 NR G or R 1-4x 2000-12.000 0,38-0,40 
Haffner47 2016 58 48 (16-82) 76 Tibia 15,6 (9-56) 31,8 34,6 34,6 G or R 3000-4000 0,4 
Wang50 2009 42 35 (16-68) 52 
Diaphysis of the long 
bones of the lower 
extremities 
15,0 (6-48) NR 83 17 NR G 6000 0,62 
Kuo42 2015 22 30 (18-45) 59 Femoral shaft 10,5 (6-16) NR 0 100 0 G or R 3000 0,58 
Studies with undefined definition of delayed-union and nonunion 
Moretti33 2009a 204 NR (NR) NR Upper + lower extremities NR (NR) NR NR NR NR NR 4000 0,22-1,10 
Valchanou13 1991 82 28 (9-76) 90 Upper + lower extremities 20,2 (NR) NR NR NR NR R 1000 – 4000 
1000 – 1700 
bars 
Bara32 2007 81 NR (12-89) 68 Upper +lower extremities 8 (4-204) NR NR NR NR NA 1500-3000 500 bars 
Czarnowska-
Cubala40  2013 31 47 (21-72)  65 
Long bones of the upper + 
lower extremities 
 
NR (NR) NR NR NR NR NR 3000 300 bars 
Moretti34 2009b 10 NR (20-29) 100 Lower extremities NR (NR) NR NR NR NR NA 3x 4000 0,09-0,17 
Alvarez37 2011 34 50 (16-75) 22 
Proximal metatarsal or 
zone 2/3 of the fifth 
metatarsal 
6,8 (2,3-192,2) NR NR NR NR G or R 2000 0,22-0,51 
West45 2008 28 48 (16-75) 21 
Proximal metatarsal or 
zone 2/3 of the fifth 
metatarsal 
13,3 (2,3-19,2) NR NR NR NR 
G with 
regional 
block 
2000 
 24 kV 
DU: Delayed-union; NU: Nonunion; NR: Not reported; G: General anesthesia; R: Regional anesthesia; L: Local anesthesia; NA: No anesthesia; a: excluded from results due to <10 patients 
 
Table 5. Overall union rates of studies at high risk of bias 
 Union rate (%) Total number of 
treated patients 
Delayed-unions treated with ESWT 86 314 
Nonunions treated with ESWT 73 1782 
Nonunions treated with surgery 81 80 
Nonunions treated with hBMSC’s and ESWT 62,5 32 
 
 
Table 6. Absolute number of complications classified by the adapted Clavien-Dindo classification 
 ESWT Surgery 
 Number 
of  
patients 
Number of 
complications 
Number 
of 
patients 
Number of 
complications 
Grade 
1 
Grade 
2 
Grade 
3 
Grade 
1 
Grade 
2 
Grade 
3 
Cacchio8 2009  84 231 0 0 42 12 0 23 
Notarnicol10 2010  58 0 0 0 60 0 0 0 
Furia92010 23 14 0 0 20 15 16 97 
Overall  165 24 0 0 122 2 1 11 
1. hematomas; 2. nerve neuropraxia; 3. wound infections requiring surgical debridement and 
antibiotics; 4. mild petechiae; 5. superficial cellulitis; 6. refracture requiring five weeks of 
immobilization in a walking boot; 7. hardware removal due to symptoms related to hardware 
 
